美国神经胃肠病学与动力学会及周期性呕吐综合征协会成人周期性呕吐综合征管理指南
该指南由美国神经胃肠病学与动力学会(ANMS)和周期性呕吐综合征协会(CVSA)联合制定,采用GRADE框架并经专业图书馆员进行文献检索,专家委员会纳入CVSA主席以体现患者视角。指南针对成人CVS的预防、急性发作治疗、诊断和整体管理提出推荐。委员会强烈推荐中重度成人CVS患者接受三环类抗抑郁药(如阿米替林)作为一线预防用药,托吡酯或阿瑞匹坦作为替代预防用药;急性发作时条件性推荐使用5-HT3受体拮抗剂(如昂丹司琼)和/或曲普坦类药物(如舒马曲坦)或阿瑞匹坦终止症状。急诊科治疗最好采用个体化治疗方案并与医疗团队共享。
要点
- 成人中重度CVS:强烈推荐三环类抗抑郁药(如阿米替林)作为一线预防用药。
- 替代预防用药:托吡酯或阿瑞匹坦;条件性推荐唑尼沙胺或左乙拉西坦及线粒体补充剂(辅酶Q10、左卡尼汀、核黄素)单用或联用。
- 急性发作:条件性推荐5-HT3受体拮抗剂(如昂丹司琼)和/或曲普坦类药物(如舒马曲坦)或阿瑞匹坦终止症状。
- 急诊科治疗最好采用个体化治疗方案并与医疗团队共享(示例已提供)。
- 推荐筛查并治疗共病(焦虑、抑郁、偏头痛、自主神经功能障碍、睡眠障碍、物质使用),必要时转诊至相关辅助健康服务。
适用人群与场景
- 成人周期性呕吐综合征(CVS)患者,涵盖预防、急性发作治疗、诊断和整体管理。
处置流程与药物剂量
- 预防:成人中重度CVS强烈推荐三环类抗抑郁药(如阿米替林)作为一线预防用药。
- 预防:托吡酯或阿瑞匹坦作为替代预防用药。
- 预防:条件性推荐唑尼沙胺或左乙拉西坦及线粒体补充剂(辅酶Q10、左卡尼汀、核黄素)作为替代预防用药,可单用或与其他预防用药联用。
- 急性发作:条件性推荐使用5-HT3受体拮抗剂(如昂丹司琼)和/或曲普坦类药物(如舒马曲坦)或阿瑞匹坦终止症状。
- 急诊科治疗最好采用个体化治疗方案并与医疗团队共享(示例已提供)。
- 推荐筛查并治疗共病如焦虑、抑郁、偏头痛、自主神经功能障碍、睡眠障碍和物质使用,并根据指征转诊至相关辅助健康服务。
- 可提供冥想、放松和生物反馈等作为补充治疗以改善整体健康和患者护理结局。
研究设计与关键结果
- 制定机构:美国神经胃肠病学与动力学会(ANMS)和周期性呕吐综合征协会(CVSA);方法:采用GRADE框架,由专业图书馆员进行文献检索,专家委员会包括CVSA主席以纳入患者视角。
证据类型、等级与局限
- 证据类型:基于GRADE框架的循证指南;推荐强度包括强烈推荐和条件性推荐;局限:原文未报告局限性。
对床旁实践的改变
- 对成人中重度CVS患者,一线预防可选用三环类抗抑郁药(如阿米替林)(强烈推荐)。
- 急性发作时可考虑使用5-HT3受体拮抗剂(如昂丹司琼)和/或曲普坦类药物(如舒马曲坦)或阿瑞匹坦终止症状(条件性推荐)。
- 急诊科应采用个体化治疗方案并与医疗团队共享。
- 应筛查并治疗共病(焦虑、抑郁、偏头痛、自主神经功能障碍、睡眠障碍、物质使用),必要时转诊至相关辅助健康服务。
- 可提供冥想、放松和生物反馈等补充治疗以改善整体健康。
指南或共识出处
- 指南名称:Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association;发布机构:美国神经胃肠病学与动力学会(ANMS)和周期性呕吐综合征协会(CVSA);发表期刊:Neurogastroenterol Motil。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The increasing recognition of cyclic vomiting syndrome (CVS) in adults prompted the development of these evidence-based guidelines on the management of CVS in adults, which was sponsored by the American Neurogastroenterology and Motility Society (ANMS) and the Cyclic Vomiting Syndrome Association (CVSA). GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) framework was used and a professional librarian performed the literature search. The expert committee included the President of the CVSA who brought a patient perspective into the deliberations. The committee makes recommendations for the prophylaxis of CVS, treatment of acute attacks, diagnosis, and overall management of CVS. The committee strongly recommends that adults with moderate-to-severe CVS receive a tricyclic antidepressant (TCA), such as amitriptyline, as a first-line prophylactic medication and receive topiramate or aprepitant as alternate prophylactic medications. Zonisamide or levetiracetam and mitochondrial supplements (Coenzyme Q10, L-carnitine, and riboflavin) are conditionally recommended as alternate prophylactic medications, either alone or concurrently with other prophylactic medications. For acute attacks, the committee conditionally recommends using serotonin antagonists, such as ondansetron, and/or triptans, such as sumatriptan or aprepitant to abort symptoms. Emergency department treatment is best achieved with the use of an individualized treatment protocol and shared with the care team (example provided). The committee recommended screening and treatment for comorbid conditions such as anxiety, depression, migraine headache, autonomic dysfunction, sleep disorders, and substance use with referral to appropriate allied health services as indicated. Techniques like meditation, relaxation, and biofeedback may be offered as complementary therapy to improve overall well-being and patient care outcomes.
参考来源
- Venkatesan T, Levinthal DJ, Tarbell SE, et al. Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association. Neurogastroenterol Motil. 2019. PMID: 31241819. doi:10.1111/nmo.13604
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。